EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

An antibiotic that mediates immune destruction of senescent cancer cells

Gabriele Casagrande Raffi, Jian Chen, Xuezhao Feng, Zhen Chen, Cor Lieftink, Shuang Deng, Jinzhe Mo, Chuting Zeng, Marit Steur, Jing Wang, Onno B Bleijerveld, Liesbeth Hoekman iD und 6 weitere

Proceedings of the National Academy of Sciences · 24.12.2024 · 121 (52)

DOI: 10.1073/pnas.2417724121 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 18.12.2024. Verfasst von Gabriele Casagrande Raffi und 17 weiteren Autor:innen. Beteiligte Einrichtung: Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Amsterdam 1066 CX, The Netherlands. Hauptthemen laut MEDLINE: Cellular Senescence, Pyrans, Killer Cells, Natural. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: EC | ERC | HORIZON EUROPE European Research Council (ERC), Health Holland, Mark Foundation For Cancer Research (The Mark Foundation for Cancer Research).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Drugs that eliminate senescent cells, senolytics, can be powerful when combined with prosenescence cancer therapies. Using a CRISPR/Cas9-based genetic screen, we identify here SLC25A23 as a vulnerability of senescent cancer cells. Suppressing SLC25A23 disrupts cellular calcium homeostasis, impairs oxidative phosphorylation, and interferes with redox signaling, leading to death of senescent cells. These effects can be replicated by salinomycin, a cation ionophore antibiotic. Salinomycin prompts a pyroptosis-apoptosis-necroptosis (PAN)optosis-like cell death in senescent cells, including apoptosis and two forms of immunogenic cell death: necroptosis and pyroptosis. Notably, we observed that salinomycin treatment or SLC25A23 suppression elevates reactive oxygen species, upregulating death receptor 5 via Jun N-terminal protein kinase (JNK) pathway activation. We show that a combination of a death receptor 5 (DR5) agonistic antibody and salinomycin is a robust senolytic cocktail. We provide evidence that this drug combination provokes a potent natural killer (NK) and CD8+ T cell–mediated immune destruction of senescent cancer cells, mediated by the pyroptotic cytokine interleukin 18 (IL18).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cellular SenescencePyransKiller Cells, NaturalHumansCell Line, TumorReactive Oxygen SpeciesNecroptosisNeoplasmsCD8-Positive T-LymphocytesAnti-Bacterial AgentsReceptors, TNF-Related Apoptosis-Inducing LigandPyroptosisApoptosisAnimalsCRISPR-Cas SystemsPolyether Polyketides

Stichwörter der Autor:innen

pyroptosissenescencesenolytics

Substanzen

salinomycinPyransReactive Oxygen SpeciesAnti-Bacterial AgentsReceptors, TNF-Related Apoptosis-Inducing LigandPolyether Polyketides

Autor:innen und Institutionen

  • Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Amsterdam 1066 CX, The Netherlands.
  • State Key Laboratory of Oncology in South China, Department of Experimental Research, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.
  • Division of Molecular Carcinogenesis, The Netherlands Cancer Institute Robotic and Screening Center, The Netherlands Cancer Institute, Amsterdam 1066 CX, The Netherlands.
  • Division of Biochemistry, Proteomics facility, The Netherlands Cancer Institute, Amsterdam 1066 CX, The Netherlands.
  • Amsterdam Faculty of Medicine Location University of Amsterdam, Department of Medical Biology, Electron Microscopy Center Amsterdam, Amsterdam 1105 AZ, The Netherlands.

ORCID-Profile: Liesbeth Hoekman, Nicole van der Wel, Rene Bernards

Förderung

  • EC | ERC | HORIZON EUROPE European Research Council (ERC)
  • Health Holland
  • Mark Foundation For Cancer Research (The Mark Foundation for Cancer Research)
  • Dutch Cancer Society KWF
  • National Natural Science Foundation of China-Guangdong Joint Fund (NSFC)
  • Guangdong Basic and Applied Basic Research Foundation

Zitieren

APA

Casagrande Raffi, G., Chen, J., Feng, X., Chen, Z., Lieftink, C., Deng, S., Mo, J., Zeng, C., Steur, M., Wang, J., Bleijerveld, O. B., Hoekman, L., van der Wel, N., Wang, F., Beijersbergen, R., Zheng, J., Bernards, R., & Wang, L. (2024). An antibiotic that mediates immune destruction of senescent cancer cells. Proceedings of the National Academy of Sciences, 121(52). https://doi.org/10.1073/pnas.2417724121

Vancouver

Casagrande Raffi G, Chen J, Feng X, Chen Z, Lieftink C, Deng S, et al. An antibiotic that mediates immune destruction of senescent cancer cells. Proceedings of the National Academy of Sciences. 2024;121(52). doi:10.1073/pnas.2417724121

BibTeX
@article{CasagrandeRaffi2024,
  author = {Casagrande Raffi, Gabriele and Chen, Jian and Feng, Xuezhao and Chen, Zhen and Lieftink, Cor and Deng, Shuang and Mo, Jinzhe and Zeng, Chuting and Steur, Marit and Wang, Jing and Bleijerveld, Onno B and Hoekman, Liesbeth and van der Wel, Nicole and Wang, Feng and Beijersbergen, Roderick and Zheng, Jian and Bernards, Rene and Wang, Liqin},
  title = {An antibiotic that mediates immune destruction of senescent cancer cells},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2024},
  volume = {121},
  number = {52},
  doi = {10.1073/pnas.2417724121}
}
Kostenlos starten →